HIV-1 integrase inhibitor resistance in viraemic-treated individuals and baseline capsid diversity relevant to future lenacapavir therapy.

Abdullahi A, Osawe S, Wisso H, Edun M, Adebisi G, Arachie J, Ude C, Onyemata J, Alhaji SY, Bara Jibrin Y, Abimiku A, Kemp SA, Gupta RK

Open source

DOI: 10.1093/jac/dkag300
Published: 2026 Sep 1
Container: The Journal of antimicrobial chemotherapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/jac/dkag300,
  title = {HIV-1 integrase inhibitor resistance in viraemic-treated individuals and baseline capsid diversity relevant to future lenacapavir therapy.},
  author = {Abdullahi A and Osawe S and Wisso H and Edun M and Adebisi G and Arachie J and Ude C and Onyemata J and Alhaji SY and Bara Jibrin Y and Abimiku A and Kemp SA and Gupta RK},
  year = {2026},
  journal = {The Journal of antimicrobial chemotherapy},
  doi = {10.1093/jac/dkag300},
  url = {https://doi.org/10.1093/jac/dkag300}
}

RIS

TY  - JOUR
TI  - HIV-1 integrase inhibitor resistance in viraemic-treated individuals and baseline capsid diversity relevant to future lenacapavir therapy.
AU  - Abdullahi A
AU  - Osawe S
AU  - Wisso H
AU  - Edun M
AU  - Adebisi G
AU  - Arachie J
AU  - Ude C
AU  - Onyemata J
AU  - Alhaji SY
AU  - Bara Jibrin Y
AU  - Abimiku A
AU  - Kemp SA
AU  - Gupta RK
PY  - 2026
JO  - The Journal of antimicrobial chemotherapy
DO  - 10.1093/jac/dkag300
UR  - https://doi.org/10.1093/jac/dkag300
ER  -

APA

A, A., S, O., H, W., M, E., G, A., J, A., C, U., J, O., SY, A., Y, B. J., A, A., SA, K., & RK, G. (2026). HIV-1 integrase inhibitor resistance in viraemic-treated individuals and baseline capsid diversity relevant to future lenacapavir therapy.. The Journal of antimicrobial chemotherapy. https://doi.org/10.1093/jac/dkag300

Source records

pubmed · retrieved 2026-09-25T07:14:50.099Z